Robert Townsend, et al v. GlaxoSmithKline, LLC, et al
| ROBERT TOWNSEND and JAMES MARTIN |
| GLENMARK PHARMACEUTICALS, INC. USA, MARLENE J. GOLDENBERG, APOTEX CORP., MICHAEL MCCANDLESS, BRAD ALRDRIGE, GLAXOSMITHKLINE, LLC, PFIZER, INC., DR. REDDY'S LABORATORIES, L. PERRIGO COMPANY, PAR PHARMACEUTICAL, INC., RANBAXY INC., SANDOZ, INC., SUN PHARMACEUTICAL INDUSTRIES, INC., TEVA PHARMACEUTICALS USA, INC., WOCKHARDT LTD., WALGREENS and MYLAN PHARMACEUTICALS, INC. |
| 23-11080 |
| April 6, 2023 |
| U.S. Court of Appeals, Eleventh Circuit |
| Health Care / Pharma |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 22, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 14 Response filed by Lisa Marie Baird for Par Pharmaceutical, Inc. pursuant to court order dated 05/08/2023. [23-11080] (ECF: Lisa Baird) [Entered: 05/22/2023 04:16 PM] |
| Filing 13 NOTICE OF CIP FILING DEFICIENCY to Robyn Maguire for Walgreens. You are receiving this notice because you have not completed the Web-Based Stock Ticker Symbol Certificate of Interested Persons (CIP) via the Court's public web-page. Failure to comply with 11th Cir. Rules 26.1-1 through 26.1-4 may result in dismissal of the case or appeal under 11th Cir. R. 42-1(b), return of deficient documents without action, or other sanctions on counsel, the party, or both. If you are an appellant or petitioner, upon expiration of 14 days from the date of this notice, your appeal will be dismissed for want of prosecution if the default has not been remedied, pursuant to 11th Cir. Rules 26.1-5(c) and 42-1(b). If you are an appellee or respondent, no action will be taken on documents submitted until the CIP deficiency is remedied. See 11th Cir. R. 26.1-5. [Entered: 05/18/2023 12:31 PM] |
| Filing 12 APPEARANCE of Counsel Form filed by Sarah E. Johnston for Walgreen Co. Related cases? Yes. [23-11080] (ECF: Sarah Johnston) [Entered: 05/17/2023 11:02 AM] |
| Filing 11 Certificate of Interested Persons and Corporate Disclosure Statement filed by Robyn S. Maguire for Walgreen Co.. On the same day the CIP is served, any filer represented by counsel must also complete the court's web-based stock ticker symbol certificate at the link here http://www.ca11.uscourts.gov/web-based-cip or on the court's website. See 11th Cir. R. 26.1-1(b). [23-11080] (ECF: Robyn Maguire) [Entered: 05/17/2023 10:57 AM] |
| Filing 10 APPEARANCE of Counsel Form filed by Robyn S. Maguire for Walgreen Co. Related cases? Yes. [23-11080] (ECF: Robyn Maguire) [Entered: 05/17/2023 10:52 AM] |
| Filing 9 Removed from case: Attorney Steven L. Nicholas for Appellant Robert Townsend in 23-11080. [Entered: 05/10/2023 08:12 AM] |
| Filing 8 Request for Representation Correction filed by Attorney Steven L. Nicholas for Appellant Robert Townsend. [23-11080] (ECF: Steven Nicholas) [Entered: 05/09/2023 11:59 AM] |
| Filing 7 JURISDICTIONAL QUESTION issued as to James Martin, Robert Townsend and Brad Alrdrige, Apotex Corp., Glenmark Pharmaceuticals, Inc. USA, Michael McCandless and Par Pharmaceutical, Inc. [Entered: 05/08/2023 12:45 PM] |
| Filing 6 NOTICE OF CIP FILING DEFICIENCY to Lisa Marie Baird for Par Pharmaceutical, Inc.. You are receiving this notice because you have not completed the Web-Based Stock Ticker Symbol Certificate of Interested Persons (CIP) via the Court's public web-page. Failure to comply with 11th Cir. Rules 26.1-1 through 26.1-4 may result in dismissal of the case or appeal under 11th Cir. R. 42-1(b), return of deficient documents without action, or other sanctions on counsel, the party, or both. If you are an appellant or petitioner, upon expiration of 14 days from the date of this notice, your appeal will be dismissed for want of prosecution if the default has not been remedied, pursuant to 11th Cir. Rules 26.1-5(c) and 42-1(b). If you are an appellee or respondent, no action will be taken on documents submitted until the CIP deficiency is remedied. See 11th Cir. R. 26.1-5. [Entered: 04/18/2023 09:37 AM] |
| Filing 5 Certificate of Interested Persons and Corporate Disclosure Statement filed by Attorney Lisa Marie Baird for Appellee Par Pharmaceutical, Inc.. On the same day the CIP is served, any filer represented by counsel must also complete the court's web-based stock ticker symbol certificate at the link here http://www.ca11.uscourts.gov/web-based-cip or on the court's website. See 11th Cir. R. 26.1-1(b). [23-11080] (ECF: Lisa Baird) [Entered: 04/13/2023 04:40 PM] |
| Filing 4 MOTION for suggestion of bankruptcy filed by Par Pharmaceutical, Inc.. Opposition to Motion is Unknown. [4] [23-11080] (ECF: Lisa Baird) [Entered: 04/13/2023 04:38 PM] |
| Filing 3 APPEARANCE of Counsel Form filed by Lisa M. Baird for Par Pharmaceutical, Inc. [23-11080] (ECF: Lisa Baird) [Entered: 04/12/2023 10:56 AM] |
| Filing 2 CIVIL APPEAL DOCKETED. Notice of appeal filed by Appellant James Martin on 04/06/2023. Fee Status: IFP Granted. 04/06/2023 Awaiting Appellant's Certificate of Interested Persons due on or before 04/25/2023 as to Appellant James Martin. Awaiting Appellee's Certificate of Interested Persons due on or before 05/09/2023 as to Appellees Brad Alrdrige, Apotex Corp., Glenmark Pharmaceuticals, Inc. USA and Michael McCandless [Entered: 04/11/2023 10:40 AM] |
| Filing 1 CIVIL APPEAL DOCKETED. Notice of appeal filed by Appellant Robert Townsend on 04/05/2023. Fee Status: Fee Paid. 04/06/2023 Awaiting Appellant's Certificate of Interested Persons due on or before 04/21/2023 as to Appellant Robert Townsend [Entered: 04/07/2023 04:51 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
